Диссертация (1141102), страница 18
Текст из файла (страница 18)
– 2008. №58(5). – Р.1505-1515.156.Gill, G.V. Surgery in patients with diabetes mellitus. In: Textbook ofDiabetes / Ed….. J.C. Pickup, G. Williams. Blackwell Science Ltd., 2003. – p.411-419.157.Goldbach-Mansky, R. Autoinflammation: the prominent role of IL-1 inmonogenic autoinflammatory diseases and implications for common illnesses / R.Goldbach-Mansky, D.L.
Kastner // J Allergy Clin Immunol. – 2009. - №124(6). –Р.1141-1149.158.Goldbach-Mansky, R. Neonatal-onset multisystem inflammatory diseaseresponsive to interleukin-1beta inhibition / R. Goldbach-Mansky, N.J. Dailey,S.W. Canna, et al. // N Engl J Med.
– 2006. - №355(6). – Р.581-592.159.Guma, M. Caspase 1-independent activation of interleukin-1beta inneutrophil-predominant inflammation / M. Guma, L. Ronacher, R. Liu-Bryan //Arthritis Rheum. – 2009. - №60(12). – Р.3642-3650.160.Ha Van, G.S.H. Treatment of osteomyelitis in the diabetic foot:contribution of conservative surgery / G.S.H.
Ha Van, J.P. Danan // DiabetesCare. – 2006. – vol. 19. – p. 1257-1260.105161.Han, P. Diabetic foot wound care algorithms / P.Han, R. Ezquerro // J. Am.Podiatr. Med. Assoc. – 2002. – vol. 92. – p. 336-349.162.Hoffman, H.M. Efficacy and safety of rilonacept (interleukin-1 trap) inpatients with cryopyrin-associated periodic syndromes: results from twosequential placebo-controlled studies / H.M.
Hoffman, M.L. Throne, N.J. Amar,et al. // Arthritis Rheum. – 2008. - №58(8). – Р.2443-2452.163.Hogge, J. The potential benefits of advanced therapeutic modalities in thetreatment of diabetic foot wounds / J. Hogge // J. Am. Podiatr Med Assoc. –2000. – Vol. 90. – p. 57-65.164.Jeffcoate W.J. Diabetic foot ulcers. / W.J.
Jeffcoate, K.G. Harding //Lancet. – 2003. – Vol. 361. – P. 1545-1551.165.Joosten, L.A. Engagement of fatty acids with Toll-like receptor 2 drivesinterleukin-1beta production via the ASC/caspase 1 pathway in monosodiumurate monohydrate crystal-induced gouty arthritis / L.A. Joosten, M.G.
Netea, E.Mylona, et al. // Arthritis Rheum. – 2010 .- №62(11). – Р.3237-3248.166.Joosten,L.A.Excessiveinterleukin-1signalingdeterminesthedevelopment of Th1 and Th17 responses in chronic inflammation / L.A. Joosten// Arthritis Rheum. – 2010. - №62(2). – Р.З320-3322.167.Joosten, L.A. Inflammatory arthritis in caspase 1 gene-deficient mice:contribution of proteinase 3 to caspase 1-independent production of bioactiveinterleukin-1beta / L.A.
Joosten, M.G. Netea, G. Fantuzzi, et al. // ArthritisRheum. – 2009. - №60(12). – Р.3651-3662.168.Kelk, P. IL-1beta secretion induced by Aggregatibacter (Actinobacillus)actinomycetemcomitans is mainly caused by the leukotoxin / P. Kelk, R.Claesson, C. Chen, A. Sjostedt, A. Johansson // Int J Med Microbiol. – 2008.
№298(5–6). – Р.529-541.169.Khatri, G. Effect of bone biopsy in guiding antimicrobial therapy forosteomyelitis complicating open wounds / G. Khatri, D.K. Wagner, P.G. Sohnle// Am. J. Med. Sci. – 2001. – Vol. 321. – p. 361-367.106170.Koenders, M.I. Interleukin-1 drives pathogenic Th17 cells duringspontaneous arthritis in interleukin-1 receptor antagonist-deficient mice / M.I.Koenders, I. Devesa, R.J. Marijnissen, et al. // Arthritis Rheum.
-2008. -№58(11). – Р.3461-3470.171.Krelin,Y.Interleukin-1beta-driveninflammationpromotesthedevelopment and invasiveness of chemical carcinogen-induced tumors / Y.Krelin, E. Voronov, S. Dotan, et al // Cancer Res. – 2007. - №67(3). – Р.10621071.172.Lachmann, H.J. In vivo regulation of interleukin 1beta in patients withcryopyrin-associated periodic syndromes / H.J. Lachmann, P. Lowe, S.D. Felix,et al. // J Exp Med. – 2009.
- №206(5). – Р.1029-1036.173.Lachmann, H.J. Use of canakinumab in the cryopyrin-associated periodicsyndrome / H.J. Lachmann, I. Kone-Paut, J.B. Kuemmerle-Deschner, et al. // NEngl J Med. – 2009. - №360(23). Р.2416-2425.174.Lamacchia, C. Enhanced Th1 and Th17 responses and arthritis severity inmice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist /C. Lamacchia, G.
Palmer, C.A. Seemayer // Arthritis Rheum. – 2010. - №62(2). –Р.452-462.175.Larsen, C.M. Interleukin-1-receptor antagonist in type 2 diabetes mellitus./ C.M. Larsen, M. Faulenbach, A. Vaag, et al. // N Engl J Med. – 2007. №356(15). – Р.1517-1526.176.Larsen, C.M. Sustained effects of interleukin-1 receptor antagonisttreatment in type 2 diabetes / C.M. Larsen, M. Faulenbach, A. Vaag // DiabetesCare. – 2009. - №32(9). – Р.1663-1668.177.Lech, M.
Resident dendritic cells prevent postischemic acute renal failureby help of single Ig IL-1 receptor-related protein / M. Lech, A. Avila-Ferrufino,R. Allam, et al. // J Immunol. – 2009. - №183(6). – Р.4109-4118.178.Ledermann, H.P. Pedal abscess in patients suspected of having pedalosteomyelitis: analysis with MR imaging. / H.P. Ledermann, W.B. Morrison,M.E. Schwweitzer // Radiology. – 2002. – Vol. 224 – P. 649-655.107179.Levin, M.E. The Diabetic Foot / M.E.
Levin, L.W. O’Neal // BooksEdition. London: 2001. – 828 p.180.Lew, D. Osteomyelitis / D. Lew, F. Waldvogel // Lancet. – 2004. – Vol.364. – p. 369-379.181.Lipsky, B.A. Infectious problems of the foot in diabetic patients / In: J.H.Bowker, M.A. Pfeifer, editors // The diabetic foot. 6th ed. - St. Louis: Mosby.
2001. - Р. 467-480.182.Lust, J.A. Induction of a chronic disease state in patients with smolderingor indolent multiple myeloma by targeting interleukin 1beta-induced interleukin 6production and the myeloma proliferative component / J.A. Lust, M.Q. Lacy, S.R.Zeldenrust, et al // Mayo Clin Proc. - 2009. -№84(2). – Р. 114-122.183.Mandrup-Poulsen, T. Blockade of interleukin 1 in type 1 diabetes mellitus/ T.
Mandrup-Poulsen, L. Pickersgill, M.Y. Donath // Nat Rev Endocrinol. -2010.- №6(3). – Р.158-166.184.Marrack, P. Towards an understanding of the adjuvant action ofaluminium / P. Marrack, A.S. McKee, M.W. Munks // Nat Rev Immunol. -2009.-№9(4). – Р.287-293.185.Martinon, F. The inflammasomes: guardians of the body / F. Martinon, A.Mayor, J.
Tschopp // Annu Rev Immunol. – 2009. - №27. – Р.229-265.186.Masters, S.L. Horror autoinflammaticus: the molecular pathophysiology ofautoinflammatory disease / S.L. Masters, A. Simon, I. Aksentijevich // Annu RevImmunol. – 2009. - №27. – Р. 621-668.187.Masters. S.L. Activation of the NLRP3 inflammasome by islet amyloidpolypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes / S.L.Masters, A. Dunne, S.L. Subramanian, et al. // Nat Immunol. - 2010. - №11(10).– Р.897-904.188.Meissner, F. Inflammasome activation in NADPH oxidase defectivemononuclear phagocytes from patients with chronic granulomatous disease / F.Meissner, R.A.
Seger, D. Moshous // Blood. – 2010. - №116(9). – Р.1570-1573.108189.Meissner, F. Superoxide dismutase 1 regulates caspase-1 and endotoxicshock / F. Meissner, K. Molawi, A. Zychlinsky // Nat Immunol. – 2008. -№9(8).– Р. 866-872.190.Miller, A.O. Update in diagnosis and treatment of diabetic foot infections /A.O. Miller, M. Henry // Phys. Med.
Reabil. Clin. N Am. – 2009. – vol. 20. – p.611-25.191.Morrison, W.B. MR imaging of inflammatory conditions of the ankle andfoot. / W.B. Morrison, H.P. Ledermann, M.E. Schweitzer // Magn. Reson.Imaging Clin. N. Am. – 2001. – Vol. 9. – P. 615-637.192.Netea, M.G. Differential requirement for the activation of theinflammasome for processing and release of IL-1beta in monocytes andmacrophages / M.G. Netea, C.A.
Nold-Petry, M.F. Nold, et al. // Blood. – 2009. №113(10). – Р.2324-2335.193.Nold, M.F. IL-37 is a fundamental inhibitor of innate immunity / M.F.Nold, C.A. Nold-Petry, J.A. Zepp // Nat Immunol. – 2010. - №11(11). – Р.10141022.194.Okamoto, M. Constitutively active inflammasome in human melanomacells mediating autoinflammation via caspase-1 processing and secretion ofinterleukin-1beta / M. Okamoto, W.
Liu, Y. Luo, et al. // J Biol Chem. – 2009. №285(9). - Р.6477-6488.195.O'Neill, L.A. The interleukin-1 receptor/Toll-like receptor superfamily: 10years of progress / L.A. O'Neill // Immunol Rev. – 2008. - №226. – Р.10-18.196.O'Neill, L.A. Therapeutic targeting of toll-like receptors for infectious andinflammatory diseases and cancer / L.A. O'Neill, C.E. Bryant, S.L. Doyle //Pharmacol Rev. – 2009. - №61(2). – Р.177-197.197.Palestro, C.J. Infections and musculoskeletal conditions: Imaging ofmusculoskeletal infections / C.J. Palestro, C.
Love, T.T. Miller // Best Pract. Res.Clin. Rheumatol. – 2006. – V. 20, №6. - 1197-1218.109198.Pascual, V. Role of interleukin-1 (IL-1) in the pathogenesis of systemiconset juvenile idiopathic arthritis and clinical response to IL-1 blockade / V.Pascual, F. Allantaz, E. Arce // J Exp Med. – 2005. - №201(9). – Р.1479-1486.199.Peters, K.M. Immune reactions in chronic post-traumatic osteomyelitis.Сurrent status determination / K.M. Peters, К. Koberg, G. Zwadlo-Klarwasser,K.W. Zilkens // Orthop.
Ihre Grenzgeb. – 1991 – V. 129(4). – P. 313-408.200.Pineda. C. Imaging of osteomyelitis: current concepts / C. Pineda, A.Vargas, A.V. Rodriguez // Infect. Dis. Clin. North. Am. – 2006 –V. 20, №4.Р.789-825.201.Reddy, S. An autoinflammatory disease due to homozygous deletion of theIL1RN locus / S. Reddy, S. Jia, R. Geoffrey, et al.
// N Engl J Med. – 2009. №360(23). – Р.2438-2444.202.Rosenberg, Z.A. MR imaging of the ankle and foot / Z.A. Rosenberg, JBeltran, J.T. // Bencardino Radio Graphics. – 2000. – V. 20. – Р. 153-179.203.Shank, C.F. Osteomyelitis in the diabetic foot: diagnosis and management /C.F. Shank, J.B. Feibel // Foot Ankle Clin. – 2006. – V. 11, №4. – Р.
775-789.204.Sharma, S. The IL-1 family member 7b translocates to the nucleus anddown-regulates proinflammatory cytokines / S. Sharma, N. Kulk, M.F. Nold, etal. // J Immunol. – 2008. - №180(8). – Р. 5477-5482.205.Sia, I.G. Infection and musculoskeletal conditions: Osteomyelitis / I.G. Sia,E.F. Berbari // Best Pract. Res. Clin.
Rheumatol. – 2006. – V. 20, №6. – Р. 10651081.206.Simon, A. Pathogenesis of familial periodic fever syndromes or hereditaryautoinflammatory syndromes / A. Simon, J.W. van der Meer // Am J PhysiolRegul Integr Comp Physiol. – 2007. - №292(1). – Р. 86-98.207.Slater, R. Swab cultures accurately identify bacterial pathogens in diabeticfoot wounds not involving bone / R. Slater, T. Lasarovitch, I.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
